Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei .

Based on crystal structures of Trypanosoma brucei methionyl-tRNA synthetase ( Tb MetRS) bound to inhibitors, we designed, synthesized, and evaluated two series of novel Tb MetRS inhibitors targeting this parasite enzyme. One series has a 1,3-dihydro-imidazol-2-one containing linker, the other has a rigid fused aromatic ring in the linker. For both series of compounds, potent inhibition of parasite growth was achieved with EC ₅₀ < 10 nM and most compounds exhibited low general toxicity to mammalian cells with CC ₅₀ s > 20 000 nM. Selectivity over human mitochondrial methionyl tRNA synthetase was also evaluated, using a cell-based mitochondrial protein synthesis assay, and selectivity in a range of 20-200-fold was achieved. The inhibitors exhibited poor permeability across the blood brain barrier, necessitating future efforts to optimize the compounds for use in late stage human African trypanosomiasis.
(This journal is © The Royal Society of Chemistry 2020.)